XEPOL
LIVE

Serial Number

79112805

Owner

GRIFOLS, S.A.

Filing Date

Mar 13, 2012

Add to watchlist:

No watchlists yet
View on USPTO

XEPOL Trademark

Serial Number: 79112805 • Registration: 4228499

XEPOL is a trademark filed by GRIFOLS, S.A. on March 13, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GRIFOLS, S.A. (61 trademarks)

CALLE MARINA, 16-18, TORRE MAPFRE, 26TH
BARCELONA , ES

Entity Type: 03

Trademark Details

Filing Date

March 13, 2012

Registration Date

October 23, 2012

Published for Opposition

August 7, 2012

Cancellation Date

March 14, 2022

Goods & Services

Immunoglobulin for the treatment of post-polio syndrome

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Oct 1, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 1, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 20, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 20, 2020 INTS
INVALIDATION PROCESSED
Feb 19, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 24, 2020 INTR
CANCELLED SECTION 71
May 24, 2019 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Sep 13, 2018 NREP
NOTIFICATION PROCESSED BY IB
Jan 5, 2013 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 3, 2012 FICS
FINAL DISPOSITION PROCESSED
Dec 3, 2012 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 22, 2012 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 23, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Sep 23, 2012 GPNX
PUBLISHED FOR OPPOSITION
Aug 7, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 1, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 1, 2012 OP2R
NOTICE OF PUBLICATION
Jul 18, 2012 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2012 CNSA
ASSIGNED TO EXAMINER
Jun 20, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 15, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2012 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 7, 2012 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 5, 2012 REPR